Market Cap | ₹944Cr |
ROE | 11.36% |
P/E Ratio(TTM) | 32.48 |
EPS(TTM) | 24.67 |
P/B Ratio | 3.69 |
Dividend Yield | 0.09% |
Industry P/E | 35.77 |
Book Value | 217.13 |
Debt to Equity | 0.09 |
Face Value | 10 |
Parent Organisation | Remus Pharmaceuticals |
Managing Director | Mr. Arpit Shah |
NSE Symbol | REMUS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Biocon | NA (0.00%) | 128.21 | ||
Anthem Biosciences | NA (0.00%) | 105.32 | ||
Onesource Specialty Pharma | NA (0.00%) | 308.61 | ||
Advanced Enzyme Technologies | NA (0.00%) | 27.74 |